Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Janssen obtains worldwide license to develop and market norastemizole

Feb. 5, 1998

Heterocyclic bradykinin antagonists from Hoechst

Feb. 4, 1998

Antifibrotic compounds discovered at Hoechst

Feb. 4, 1998

Heterocyclic bradykinin antagonists in development at Hoechst Marion Roussel

Feb. 3, 1998

Bronchodilating and antiinflammatory effects of SCA-40 studied in vitro and in vivo

Feb. 2, 1998

Inhibitors of the production or release of sCD23, TNF

Jan. 29, 1998

Progenitor and Affymetrix collaborate on asthma research

Jan. 27, 1998

New heterocyclic bradykinin antagonists from Fujisawa

Jan. 26, 1998

TNF-alpha inhibitors disclosed by Celgene

Jan. 23, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...